Clinical Scientist, National RTTQA Group | East and North Hertfordshire NHS Trust
| Posting date: | 28 March 2024 |
|---|---|
| Salary: | Not specified |
| Additional salary information: | £43,742 - £50,056 per annum, plus 15% High Cost Area Supplement |
| Hours: | Full time |
| Closing date: | 27 April 2024 |
| Location: | Northwood, HA6 2RN |
| Company: | East and North Hertfordshire NHS Trust |
| Job type: | Contract |
| Job reference: | 6192604/361-CAN-6116159-A |
Summary
We are recruiting for a Clinical Scientist, National RTTQA Group who shares our vision to be trusted to provide consistently outstanding care and exemplary service to our patients.
The National Radiotherapy Trials Quality Assurance (RTTQA) Group is a centralised UK resource which designs and implements QA programmes for all NIHR CRN Portfolio trials that include a radiotherapy component. The group exists as a single multi-professional network of radiographers, clinical scientists, clinicians and IT staff working collaboratively across a number of NHS sites.
The RTTQA Group monitors the quality of radiotherapy delivery for multicentre clinical trials. Poor quality radiotherapy can compromise the outcome of a trial and may also have negative consequences on patient outcomes. Radiotherapy Quality Assurance (RT QA) is recognised as an integral and essential part of the radiotherapy clinical trial process.
This is a great opportunity, ideal for those looking to broaden their radiotherapy experience and knowledge, to join the group. The ideal candidate will be enthusiastic, motivated, have exemplary communication skills and enjoy working as part of a dynamic team.
Our Values areInclude,Respect andImprove. It is important that you understand and refer to our values during your recruitment process and beyond!
You will be the lead contact for a number of trials, performing or assisting with all aspects of RT QA, including protocol development, contour and planning reviews, and dosimetry audit. You will work closely with trial recruiting centres and support trial participation through interactive workshops and site visits. You will have the chance to collaborate with national and international groups, showcase work at meetings and conferences and be supported in undertaking post-graduate study.
This is an exciting time in radiotherapy addressing high level RT QA and audit for radiotherapy trials.
The post holder will work within the RTTQA Group, coordinated from Mount Vernon Cancer Centre which is situated 30 minutes from central London on the metropolitan line, and is one of the largest radiotherapy centres in the UK. There may be the opportunity to be based at one of the other RTTQA sites on request. The RTTQA Group has been centrally funded through the NIHR CRN since April 2010 and as such the post is for 1 year but renewable annually subject to funding position.
Prospective applicants are welcome to discuss this post, in particular the opportunities for part-time and flexible working and alternative RTTQA site base with Elizabeth Miles (RTTQA Group lead) elizabeth.miles@nhs.net 02038262329.
Applicants not meeting the person specification at band 7 and anticipating registration as a clinical scientist within 12 months may be considered for a post at band 6.
At East and North Hertfordshire NHS Trust, we are proud of the range of general and specialist services we provide and our 6,000 or so dedicated staff ensure our patients get the best care. Our ability to be flexible and innovative in the way in which we work and deliver our services to our catchment has never been more important than it is now.
We run the following hospitals:
• The Lister Hospital, Stevenage
• New Queen Elizabeth II (New QEII), Welwyn Garden City
• Hertford County, Hertford
• Mount Vernon Cancer Centre (MVCC), Northwood
We have ambitious plans to become an outstanding, patient-led Trust where dedicated staff provide high-quality, compassionate care to our patients. We continue to undergo significant transformation and our staff and patients are at the heart of delivering this ambitious agenda.
We are committed to a positive work life balance for our employees. This means that any employee is entitled to seek to work flexible working patterns and we are committed to listen and consider all requests. Such requests, of course, have to be made and considered formally, and will need to be balanced against service needs, but our starting point will always be to find ways to support making them happen.
ENHT is seeking to maintain and expand the Mount Vernon Cancer Centre staff as we move to an exciting new future.
We welcome applications from those who would relish the opportunity to be part of new and developing cancer service, building on the excellent reputation, research and patient experience the Cancer Centre already delivers.
In the UK new technologies and techniques are used and often introduced in clinical trials. The RTTQA Group engages early in the clinical trial development process. You would have the opportunity to be involved in practice changing developments in areas including proton beam therapy, adaptive treatments, MR-Linac, SABR and SRS.
In addition, you will receive a High Cost Area Supplement of 15% of your basic salary, subject to a minimum payment of £4,314 and a maximum payment of £5,436 per annum pro rata.Please see the attached Job Description and Person Specification information pack for further detailed information regarding this role.
This advert closes on Monday 15 Apr 2024